EMMPRIN expression in tongue squamous cell carcinoma

Journal of Oral Pathology and Medicine

Volumn 38, Issue 6, 2009, Pages 518-523

  Huang, Zhiquan ^a   Huang, Hongzhang ^b   Li, Haigang ^a   Chen, Weiliang ^a   Pan, Chaobin ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b Institute of Stomatological Research   (China)

Author keywords

Extracellular matrix metalloproteinase inducer; Prognosis; Tongue squamous cell carcinoma

Indexed keywords

CD147 ANTIGEN; SQUAMOUS CELL CARCINOMA ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA; TUMOR CLASSIFICATION; TUMOR VOLUME;

ADULT; AGED; ANTIGENS, CD147; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; EPITHELIUM; FEMALE; FOLLOW-UP STUDIES; GLOSSECTOMY; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TONGUE; TONGUE NEOPLASMS;

EID: 67650751430     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2009.00775.x     Document Type: Article

References (25)

1. Neville BW, Day TA. Oral cancer and precancerous lesions. CA Cancer J Clin 2002 52 : 195 215. (Pubitemid 34884869)
2. Sessions DG, Spector GJ, Lenox J, et al. Analysis of treatment results for oral tongue cancer. Laryngoscope 2002 112 : 616 25.
3. Laimer K, Fong D, Gastl G, et al. EpCAM expression in squamous cell carcinoma of the oral cavity: frequency and relationship to clinicopathologic features. Oral Oncol 2008 44 : 72 7.
4. Siwik DA, Kuster GM, Brahmbhatt JV, et al. EMMPRIN mediates beta-adrenergic receptor-stimulated matrix metalloproteinase activity in cardiac myocytes. J Mol Cell Cardiol 2008 44 : 210 7.
5. Tsai WC, Chao YC, Sheu LF, et al. EMMPRIN and fascin overexpression associated with clinicopathologic parameters of pancreatobiliary adenocarcinoma in Chinese people. APMIS 2007 115 : 929 38.
6. Marieb EA, Zoltan-Jones A, Li R, et al. Emmprin promotes anchorage-independent growth in human mammary carcinoma cells by stimulating hyaluronan production. Cancer Res 2004 64 : 1229 32.
7. Quemener C, Gabison EE, Naïmi B, et al. Extracellular matrix metalloproteinase inducer up-regulates the urokinase-type plasminogen activator system promoting tumor cell invasion. Cancer Res 2007 67 : 9 15. (Pubitemid 46142753)
8. Tang Y, Nakada MT, Kesavan P, et al. Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases. Cancer Res 2005 65 : 3193 9.
9. Davidson B, Goldberg I, Berner A, et al. EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma. Clin Exp Metastasis 2003 20 : 161 9.
10. Bordador LC, Li X, Toole B, et al. Expression of EMMPRIN by oral squamous cell carcinoma. Int J Cancer 2000 85 : 347 52.
11. Chen ZN, Mi L, Xu J, et al. Targeting radioimmunotherapy of hepatocellular carcinoma with iodine (131I) metuximab injection: clinical phase I/II trials. Int J Radiat Oncol Biol Phys 2006 65 : 435 44.
12. Zucker S, Hymowitz M, Rollo EE, et al. Tumorigenic potential of extracellular matrix metalloproteinase inducer. Am J Pathol 2001 158 : 1921 8.
13. Sienel W, Polzer B, Elshawi K, et al. Cellular localization of EMMPRIN predicts prognosis of patients with operable lung adenocarcinoma independent from MMP-2 and MMP-9. Mod Pathol 2008 21 : 1130 8.
14. Nabeshima K, Iwasaki H, Koga K, et al. EMMPRIN (basigin/CD147): matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression. Pathol Int 2006 56 : 359 67.
15. Suzuki S, Sato M, Senoo H, et al. Direct cell-cell interaction enhances pro-MMP-2 production and activation in co-culture of laryngeal cancer cells and fibroblasts: involvement of EMMPRIN and MT1-MMP. Exp Cell Res 2004 293 : 259 66.
16. Riethdorf S, Reimers N, Assmann V, et al. High incidence of EMMPRIN expression in human tumors. Int J Cancer 2006 119 : 1800 10.
17. Dang D, Atakilit A, Ramos DM. EMMPRIN modulates migration and deposition of TN-C in oral squamous carcinoma. Anticancer Res 2008 28 : 2049 54.
18. Cheng MF, Tzao C, Tsai WC, et al. Expression of EMMPRIN and matriptase in esophageal squamous cell carcinoma: correlation with clinicopathological parameters. Dis Esophagus 2006 19 : 482 6.
19. Erdem NF, Carlson ER, Gerard DA, et al. Characterization of 3 oral squamous cell carcinoma cell lines with different invasion and/or metastatic potentials. J Oral Maxillofac Surg 2007 65 : 1725 33.
20. Zheng HC, Takahashi H, Murai Y, et al. Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis. Br J Cancer 2006 95 : 1371 8.
21. Vigneswaran N, Beckers S, Waigel S, et al. Increased EMMPRIN (CD 147) expression during oral carcinogenesis. Exp Mol Pathol 2006 80 : 147 59.
22. Zhong WD, Han ZD, He HC, et al. CD147, MMP-1, MMP-2 and MMP-9 protein expression as significant prognostic factors in human prostate cancer. Oncology 2008 75 : 230 6.
23. Ju XZ, Yang JM, Zhou XY, et al. EMMPRIN expression as a prognostic factor in radiotherapy of cervical cancer. Clin Cancer Res 2008 14 : 494 501.
24. Jia L, Cao J, Wei W, et al. CD147 depletion down-regulates matrix metalloproteinase-11, vascular endothelial growth factor-A expression and the lymphatic metastasis potential of murine hepatocarcinoma Hca-F cells. Int J Biochem Cell Biol 2007 39 : 2135 42.
25. Migaldi M, Sartori G, Rossi G, et al. Tumor cell proliferation and microsatellite alterations in human ameloblastoma. Oral Oncol 2008 44 : 50 60. (Pubitemid 350251279)